{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:35:12Z","timestamp":1792816512752,"version":"4.5.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted across five English-language databases: PubMed, Embase, Cochrane Library, Web of Science, and MEDLINE. The search period spanned from the inception of each database to May 31, 2,025. The baseline characteristics and data from the included studies were extracted and analyzed. Meta-analysis and trial sequential analysis (TSA) were performed using RevMan 5.3 and TSA 0.9.5.10 beta, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of nine studies involving 478 patients were included in this meta-analysis. The pooled results demonstrated that, compared with the placebo group, probiotic supplementation significantly reduced levels of low-density lipoprotein cholesterol (LDL-C) [mean difference [MD] \u221211.16, 95% confidence interval [CI] \u221218.82 to \u22123.50,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004], total cholesterol (TC) (MD \u22129.32, 95% CI \u221218.01 to \u22120.63,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.04), fasting blood glucose (FBG) (MD \u22127.82, 95% CI \u221215.60 to \u22120.04,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.05), and insulin (MD \u22122.47, 95% CI \u22124.16 to \u22120.78,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004), and increased high-density lipoprotein cholesterol (HDL-C) levels (MD 2.24, 95% CI 0.61 to 3.87,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007). No significant effects were observed on very-low-density lipoprotein cholesterol (VLDL-C) (MD \u22122.89, 95% CI \u22126.83 to 1.05,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.15), triglyceride (TG) (MD \u221213.45, 95% CI \u221228.60 to 1.70,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.08), homeostasis model assessment of insulin resistance (HOMA-IR) (MD \u22120.43, 95% CI \u22121.13 to 0.28,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.23), QUICK (MD 0.00, 95% CI \u22120.00 to 0.01,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.25), systolic blood pressure (SBP) (MD \u22121.99, 95% CI \u22124.97 to 1.00,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.19), diastolic blood pressure (DBP) (MD \u22121.23, 95% CI \u22123.32 to 0.86,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.25), or the incidence of adverse events (MD 2.00, 95% CI 0.20 to 20.49,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.56). Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. However, the impact of probiotics on other metabolic parameters such as TC, FBG, and HDL-C remains inconclusive and requires further investigation through well-designed studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      PROSPERO CRD420251272111.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1707408","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T06:42:00Z","timestamp":1770360120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of probiotics on blood lipids, glucose and pressure in patients with coronary heart disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Zhong","sequence":"first","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Kong","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Jian","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]},{"name":"Provincial Key Laboratory of TCM Diagnostics, Hunan University of Chinese Medicine","place":["Changsha, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.annepidem.2022.02.004","article-title":"Trends of in-hospital and out-of-hospital coronary heart disease mortality in French registries during the period 2000 to 2016","volume":"69","author":"Gbokou","year":"2022","journal-title":"Ann Epidemiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ahj.2023.05.006","article-title":"Epidemiologic trends and risk factors associated with the decline in mortality from coronary heart disease in the United States, 1990\u20132019","volume":"263","author":"Ananth","year":"2023","journal-title":"Am Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"29","author":"Visseren","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","article-title":"Primary prevention of cardiovascular disease in diabetes mellitus","volume":"70","author":"Newman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.medcli.2017.11.030","article-title":"Statins: pros and cons","volume":"150","author":"Pinal-Fernandez","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3892\/etm.2019.7504","article-title":"Immunologic adverse reactions of \u03b2-blockers and the skin","volume":"18","author":"Tatu","year":"2019","journal-title":"Exp Ther Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1751-7176.2011.00508.x","article-title":"Angiotensin-converting enzyme inhibitors","volume":"13","author":"Izzo","year":"2011","journal-title":"J Clin Hypertens"},{"key":"B9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/FJC.0000000000001387","article-title":"Intestinal flora metabolite trimethylamine oxide is inextricably linked to coronary heart disease","volume":"81","author":"Zhang","year":"2023","journal-title":"J Cardiovasc Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1753425920971702","article-title":"Endotoxemia is associated with an adverse metabolic profile","volume":"27","author":"M\u00e4\u00e4tt\u00e4","year":"2021","journal-title":"Innate Immun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.21037\/atm-21-5043","article-title":"Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1161\/ATVBAHA.118.311023","article-title":"Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes","volume":"38","author":"Haghikia","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.3390\/ijms21145088","article-title":"Short-chain fatty acids (except hexanoic acid) lower NF-kB transactivation, which rescues inflammation-induced decreased apolipoprotein a-I transcription in HepG2 cells","volume":"21","author":"Tayyeb","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.3390\/ijms10093755","article-title":"The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens","volume":"10","author":"Lye","year":"2009","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1612021","DOI":"10.3389\/fnut.2025.1612021","article-title":"The beneficial effects of probiotics on patients with coronary heart disease: a systematic review and meta-analysis","volume":"12","author":"Dong","year":"2025","journal-title":"Front Nutr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1154888","DOI":"10.3389\/fcvm.2023.1154888","article-title":"Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease","volume":"10","author":"Lei","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clin res ed)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1282720","DOI":"10.3389\/fpubh.2023.1282720","article-title":"A study on the use of acupoint catgut embedding in the treatment of pre-diabetes: a meta-analysis and data mining approach","volume":"11","author":"Yu","year":"2023","journal-title":"Front Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1364546","DOI":"10.3389\/fphar.2024.1364546","article-title":"Efficacy and safety of low-dose esketamine for painless gastrointestinal endoscopy in adults: a systematic evaluation and meta-analysis","volume":"15","author":"Deng","year":"2024","journal-title":"Front Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration's Tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin res ed"},{"key":"B24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clin res ed"},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/anae.14705","article-title":"Trial sequential analysis: adding a new dimension to meta-analysis","volume":"75","author":"Shah","year":"2020","journal-title":"Anaesthesia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12602-017-9343-1","article-title":"The effects of synbiotic supplementation on carotid intima-media thickness, biomarkers of inflammation, and oxidative stress in people with overweight, diabetes, and coronary heart disease: a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Farrokhian","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/fsn3.3835","article-title":"Prebiotics plus probiotics may favorably impact on gut permeability, endocannabinoid receptors, and inflammatory biomarkers in patients with coronary artery diseases: a clinical trial","volume":"12","author":"Liu","year":"2024","journal-title":"Food Sci Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/1559827619843833","article-title":"Interactive effect of probiotics supplementation and weight loss diet on metabolic syndrome features in patients with coronary artery diseases: a double-blind, placebo-controlled, randomized clinical trial","volume":"15","author":"Moludi","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12937-021-00703-7","article-title":"Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial","volume":"20","author":"Moludi","year":"2021","journal-title":"Nutr J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1080\/1028415X.2021.1889451","article-title":"The effects of co-administration of probiotics and prebiotics on chronic inflammation, and depression symptoms in patients with coronary artery diseases: a randomized clinical trial","volume":"25","author":"Moludi","year":"2022","journal-title":"Nutr Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.clnu.2018.07.017","article-title":"The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Raygan","year":"2019","journal-title":"Clin Nutr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13098-018-0353-2","article-title":"The effects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease","volume":"10","author":"Raygan","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0010022","DOI":"10.1128\/msystems.00100-22","article-title":"Bifidobacterium lactis probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the gut-heart\/-brain axes","volume":"7","author":"Sun","year":"2022","journal-title":"Msystems"},{"key":"B36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-0042-105441","article-title":"A randomized controlled clinical trial investigating the effect of synbiotic administration on markers of insulin metabolism and lipid profiles in overweight type 2 diabetic patients with coronary heart disease","volume":"125","author":"Tajabadi-Ebrahimi","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1093\/nutrit\/nuae041","article-title":"Effects of deficiency or supplementation of riboflavin on energy metabolism: a systematic review with preclinical studies","volume":"83","author":"da Silva-Ara\u00fajo","year":"2025","journal-title":"Nutr Rev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.1007\/s12011-025-04548-7","article-title":"Unveiling the connection between micronutrients and autoimmune thyroiditis: are they true friends?","volume":"203","author":"Yu","year":"2025","journal-title":"Biol Trace Elem Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100216","DOI":"10.1016\/j.mocell.2025.100216","article-title":"Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics","volume":"48","author":"Qin","year":"2025","journal-title":"Mol Cells"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3168\/jds.2009-2574","article-title":"Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol","volume":"93","author":"Lye","year":"2010","journal-title":"J Dairy Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/10408398.2021.2004578","article-title":"Probiotics act as a potent intervention in improving lipid profile: an umbrella systematic review and meta-analysis","volume":"63","author":"Zarezadeh","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100885","DOI":"10.1016\/j.crfs.2024.100885","article-title":"Meta-analysis of the effects of probiotics on hyperlipidemia","volume":"9","author":"Yao","year":"2024","journal-title":"Curr Res Food Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/foods9111540","article-title":"Effects of probiotic supplementation on dyslipidemia in type 2 diabetes Mellitus: a meta-analysis of randomized controlled trials","volume":"9","author":"Wang","year":"2020","journal-title":"Foods"},{"key":"B44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-016-0303-y","article-title":"Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?","volume":"23","author":"Rehman","year":"2016","journal-title":"J Biomed Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","article-title":"Pathogenesis of lipid disorders in insulin resistance: a brief review","volume":"18","author":"Bjornstad","year":"2018","journal-title":"Curr Diab Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.1039\/d3fo01701j","article-title":"Lactobacillus gasseri CKCC1913 mediated modulation of the gut-liver axis alleviated insulin resistance and liver damage induced by type 2 diabetes","volume":"14","author":"Jiang","year":"2023","journal-title":"Food Funct"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1017\/S0007114513001712","article-title":"Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials","volume":"110","author":"Dong","year":"2013","journal-title":"Br J Nutr"},{"key":"B48","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/HYPERTENSIONAHA.120.16420","article-title":"Hypertension and vascular inflammation: another piece of the genetic puzzle","volume":"77","author":"Pugh","year":"2021","journal-title":"Hypertens"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertens"},{"key":"B51","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nature24628","article-title":"Salt-responsive gut commensal modulates TH17 axis and disease","volume":"551","author":"Wilck","year":"2017","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.omtn.2021.10.027","article-title":"Inhibition of microRNA-494-3p activates wnt signaling and reduces proinflammatory macrophage polarization in atherosclerosis","volume":"26","author":"van Ingen","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"B54","doi-asserted-by":"publisher","first-page":"154093","DOI":"10.1016\/j.phymed.2022.154093","article-title":"Nuanxinkang protects against ischemia\/reperfusion-induced heart failure through regulating IKK\u03b2\/I\u03baB\u03b1\/NF-\u03baB-mediated macrophage polarization","volume":"101","author":"Dong","year":"2022","journal-title":"Phytomedicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1210\/jc.2007-2176","article-title":"Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes","volume":"93","author":"Albers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jacl.2013.08.001","article-title":"High-density lipoproteins: a consensus statement from the national lipid association","volume":"7","author":"Toth","year":"2013","journal-title":"J Clin Lipidol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.3390\/ijms21051835","article-title":"The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation","volume":"21","author":"Poznyak","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3390\/ijms24043084","article-title":"Effects of berries, phytochemicals, and probiotics on atherosclerosis through gut microbiota modification: a meta-analysis of animal studies","volume":"24","author":"Khalili","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.26355\/eurrev_201904_17722","article-title":"Probiotic administration of lactobacillus rhamnosus GR-1 attenuates atherosclerotic plaque formation in ApoE-\/- mice fed with a high-fat diet","volume":"23","author":"Fang","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","article-title":"Role of gut microbiota in atherosclerosis","volume":"14","author":"Jonsson","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000484623","article-title":"Trimethylamine-N-oxide instigates NLRP3 inflammasome activation and endothelial dysfunction","volume":"44","author":"Boini","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","article-title":"Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway","volume":"97","author":"Geng","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B64","doi-asserted-by":"publisher","first-page":"151390","DOI":"10.1016\/j.bbrc.2025.151390","article-title":"Trimethylamine oxide promotes myocardial fibrosis through activating JAK2-STAT3 pathway","volume":"750","author":"Yang","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","article-title":"Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism","volume":"43","author":"Haghikia","year":"2022","journal-title":"Eur Heart J"},{"key":"B67","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.numecd.2014.01.002","article-title":"Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation","volume":"24","author":"Aguilar","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"G11","DOI":"10.1152\/ajpgi.00113.2021","article-title":"Biomarkers for assessment of intestinal permeability in clinical practice","volume":"321","author":"Seethaler","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2019.00031","article-title":"RNA-binding proteins in the control of LPS-induced macrophage response","volume":"10","author":"Ostareck","year":"2019","journal-title":"Front Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat rev","volume":"12","author":"Jia","year":"2016","journal-title":"Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","article-title":"Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1202463","DOI":"10.3389\/fendo.2023.1202463","article-title":"Diabetes-associated neutrophil NETosis: pathogenesis and interventional target of diabetic complications","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular mechanisms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2169\/internalmedicine.53.2570","article-title":"Elevated plasma cfDNA may be associated with active lupus nephritis and partially attributed to abnormal regulation of neutrophil extracellular traps (NETs) in patients with systemic lupus erythematosus","volume":"53","author":"Zhang","year":"2014","journal-title":"Intern Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aac7801","article-title":"Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis","volume":"349","author":"Nahrendorf","year":"2015","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1080\/15384101.2019.1662678","article-title":"Neutrophil extracellular traps induced by IL-8 aggravate atherosclerosis via activation NF-\u03baB signaling in macrophages","volume":"18","author":"An","year":"2019","journal-title":"Cell Cycle"},{"key":"B78","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.intimp.2013.05.018","article-title":"Lactobacillus acidophilus ATCC 4356 attenuates the atherosclerotic progression through modulation of oxidative stress and infammatory process","volume":"17","author":"Chen","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2353\/ajpath.2008.080442","article-title":"Inflammation at the molecular interface of atherogenesis: an anthropological journey","volume":"173","author":"Lamon","year":"2008","journal-title":"Am J Pathol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.1007\/s00253-020-10693-x","article-title":"Anti-atherosclerotic effects of lactobacillus plantarum ATCC 14917 in ApoE-\/- mice through modulation of proinflammatory cytokines and oxidative stress","volume":"104","author":"Hassan","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"176338","DOI":"10.1016\/j.ejphar.2024.176338","article-title":"Hegemony of inflammation in atherosclerosis and coronary artery disease","volume":"966","author":"Attiq","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12937-024-01060-x","article-title":"The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic review","volume":"24","author":"Yu","year":"2025","journal-title":"Nutr J"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1623855","DOI":"10.3389\/fnut.2025.1623855","article-title":"Global, regional, and national burden of cardiovascular disease due to dietary risks, 1990\u20132021","volume":"12","author":"Yu","year":"2025","journal-title":"Front Nutr"},{"key":"B84","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.2174\/0109298673342364241119114722","article-title":"The interplay of diet, genome, metabolome, and gut microbiome in cardiovascular disease: a narrative review","volume":"32","author":"Mofrad","year":"2025","journal-title":"Curr Med Chem"},{"key":"B85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41522-025-00695-w","article-title":"Statin therapy associated lactobacillus intestinalis attenuates pancreatic fibrosis through remodeling intestinal homeostasis","volume":"11","author":"Sui","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B86","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","article-title":"Statin therapy is associated with lower prevalence of gut microbiota dysbiosis","volume":"581","author":"Vieira-Silva","year":"2020","journal-title":"Nature"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1707408\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:58:43Z","timestamp":1771927123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1707408\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":86,"alternative-id":["10.3389\/fcvm.2026.1707408"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1707408","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"article-number":"1707408"}}